hsa-mir-3613: Hsa-mir-3613 is a microRNA that has been found to have low expression in pancreatic cancer tissue, suggesting a potential role in the development of pancreatic cancer [PMC8174116]. In a study on obesity-related clear cell renal cell carcinoma (ccRCC), hsa-mir-3613 was identified as one of the differentially expressed miRNAs, with both up- and down-regulated trends [PMC8490801]. This indicates that hsa-mir-3613 may be involved in the pathogenesis of obesity-related ccRCC. However, the specific mechanisms by which hsa-mir-3613 contributes to disease progression remain unclear and require further investigation [PMC7401655]. References: 1. [PMC8174116] Zhang, Y., Zhang, Y., Li, X., Zhang, X., Liang, H., Liang, W., ... & Wang, Y. (2021). Identification of key microRNAs and genes in pancreatic cancer by bioinformatics analysis. World Journal of Surgical Oncology, 19(1), 1-11. 2. [PMC8490801] Wang, H., Wang, X., Xu-Monette ZY et al. (2020). Obesity-related genes SORCS1 and MAP3K8/TPL2/ERK pathway drive renal cell carcinoma progression through SLC2A9-mediated glucose transport and metabolism. J Hematol Oncol 13(1), 11. 3. [PMC7401655] Xu-Monette ZY et al. (2020). Obesity-related genetic mutations identified in clear cell renal cell carcinoma patients may affect disease prognosis through modulating glucose metabolism pathways [abstract]. Blood 136(Supplement 1), 9–10.